- Home
- ARQT vs LMND Comparison
ARQT vs LMND Comparison
Compare ARQT & LMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARQT | LMND |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 4.2B |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ARQT | LMND |
|---|---|---|
| Price | $24.88 | $50.61 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 7 |
| Target Price | $34.00 | ★ $70.86 |
| AVG Volume (30 Days) | ★ 1.6M | 877.7K |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.79 | 21.40 |
| EPS | ★ 0.03 | N/A |
| Revenue | $376,072,000.00 | ★ $737,900,000.00 |
| Revenue This Year | $34.85 | $65.20 |
| Revenue Next Year | $29.39 | $33.31 |
| P/E Ratio | $813.00 | ★ N/A |
| Revenue Growth | ★ 91.34 | 40.15 |
| 52 Week Low | $16.62 | $46.16 |
| 52 Week High | $31.77 | $99.90 |
Technical Indicators
Market Signals| Indicator | ARQT | LMND |
|---|---|---|
| Relative Strength Index (RSI) | 47.67 | 41.54 |
| Support Level | $22.73 | $47.76 |
| Resistance Level | $25.25 | $56.71 |
| Average True Range (ATR) | 0.91 | 2.02 |
| MACD | -0.04 | 0.32 |
| Stochastic Oscillator | 42.09 | 10.48 |
Price Performance
Historical ComparisonAbout ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
About LMND Lemonade Inc.
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. The Company operates in one report segment providing personal property and casualty insurance products within the United States and Europe, including the UK.